CN114392496B - An acousto-optic intelligent non-destructive bone conduction therapy system - Google Patents
An acousto-optic intelligent non-destructive bone conduction therapy system Download PDFInfo
- Publication number
- CN114392496B CN114392496B CN202210003921.8A CN202210003921A CN114392496B CN 114392496 B CN114392496 B CN 114392496B CN 202210003921 A CN202210003921 A CN 202210003921A CN 114392496 B CN114392496 B CN 114392496B
- Authority
- CN
- China
- Prior art keywords
- phototherapy
- module
- parameters
- preset
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 35
- 238000002560 therapeutic procedure Methods 0.000 title claims description 167
- 230000001066 destructive effect Effects 0.000 title description 31
- 238000001126 phototherapy Methods 0.000 claims abstract description 202
- 238000012545 processing Methods 0.000 claims abstract description 66
- 238000001514 detection method Methods 0.000 claims abstract description 19
- 238000000527 sonication Methods 0.000 claims abstract 6
- 238000002604 ultrasonography Methods 0.000 claims description 26
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 18
- 239000008280 blood Substances 0.000 claims description 18
- 210000004369 blood Anatomy 0.000 claims description 18
- 230000017531 blood circulation Effects 0.000 claims description 18
- 229910052760 oxygen Inorganic materials 0.000 claims description 18
- 239000001301 oxygen Substances 0.000 claims description 18
- 238000005192 partition Methods 0.000 claims description 17
- 238000011156 evaluation Methods 0.000 claims description 16
- 210000001519 tissue Anatomy 0.000 claims description 12
- 206010020751 Hypersensitivity Diseases 0.000 claims description 7
- 230000006978 adaptation Effects 0.000 claims description 6
- 208000026935 allergic disease Diseases 0.000 claims description 5
- 230000007815 allergy Effects 0.000 claims description 5
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 238000005286 illumination Methods 0.000 abstract 1
- 230000008859 change Effects 0.000 description 23
- 230000001225 therapeutic effect Effects 0.000 description 23
- 238000000034 method Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 238000004891 communication Methods 0.000 description 10
- 230000008569 process Effects 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000031700 light absorption Effects 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 230000003828 downregulation Effects 0.000 description 4
- 230000004770 neurodegeneration Effects 0.000 description 4
- 208000015122 neurodegenerative disease Diseases 0.000 description 4
- 230000000172 allergic effect Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 238000002647 laser therapy Methods 0.000 description 3
- 210000001365 lymphatic vessel Anatomy 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 210000003625 skull Anatomy 0.000 description 3
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- 208000018737 Parkinson disease Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000011748 cell maturation Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000002219 manual therapy Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000118 neural pathway Anatomy 0.000 description 1
- 230000010004 neural pathway Effects 0.000 description 1
- 230000007658 neurological function Effects 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 238000002428 photodynamic therapy Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0093—Detecting, measuring or recording by applying one single type of energy and measuring its conversion into another type of energy
- A61B5/0095—Detecting, measuring or recording by applying one single type of energy and measuring its conversion into another type of energy by applying light and detecting acoustic waves, i.e. photoacoustic measurements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B5/02055—Simultaneously evaluating both cardiovascular condition and temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0261—Measuring blood flow using optical means, e.g. infrared light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
- A61N2007/0021—Neural system treatment
- A61N2007/0026—Stimulation of nerve tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Physiology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Pulmonology (AREA)
- Acoustics & Sound (AREA)
- Hematology (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
Description
技术领域technical field
本发明涉及生命健康技术领域,具体而言,涉及一种声光智能化无损骨传导治疗系统。The invention relates to the technical field of life and health, in particular to an acousto-optic intelligent non-destructive bone conduction therapy system.
背景技术Background technique
神经退行性疾病(Neurodegenerative diseases,NDs)是一种常见的慢性增龄性疾病,影响中枢神经系统和周围神经系统,其特征是以前完整的神经功能不可逆、进行性丧失,并随着年龄的增长而恶化,包括阿尔茨海默病(Alzheimer diseases,ADs)、帕金森病(Parkinson’s disease,PDs)等。目前,ND的主要治疗方法是药剂学,但现有的药物只能缓解症状,且有副作用,如腹泻、恶心、头痛等。此外,针对ND的病情特点,治疗不局限于医疗机构,更重要的是日常的居家护理。Neurodegenerative diseases (NDs) are common chronic aging disorders affecting the central and peripheral nervous systems and are characterized by irreversible, progressive loss of previously intact neurological function, And worsening, including Alzheimer's disease (Alzheimer diseases, ADs), Parkinson's disease (Parkinson's disease, PDs) and so on. Currently, the main treatment for ND is pharmacology, but the existing drugs can only relieve symptoms and have side effects, such as diarrhea, nausea, and headache. In addition, according to the characteristics of ND, the treatment is not limited to medical institutions, but more importantly, daily home care.
光学疗法(Light therapy,LT)是一种利用光线照射损伤部位从而缓解或治疗疾病的一种无创或微创治疗手段,无副作用。目前,光学疗法形成了包括强激光治疗、光动力治疗、弱激光治疗在内的三大光学治疗技术,已广泛应用于多种疾病的治疗。随着医学治疗模式的转变,弱激光治疗的疾病谱从常见病逐渐拓展到重大慢性增龄性疾病,治疗领域也从疾病治疗延伸到疾病预防,其应用的主战场也从医疗机构逐渐向社区和家庭倾斜。Light therapy (Light therapy, LT) is a non-invasive or minimally invasive treatment method that uses light to irradiate the damaged part to alleviate or treat the disease, without side effects. At present, optical therapy has formed three major optical therapy technologies including strong laser therapy, photodynamic therapy, and weak laser therapy, which have been widely used in the treatment of many diseases. With the transformation of the medical treatment model, the disease spectrum of weak laser therapy has gradually expanded from common diseases to major chronic aging diseases, and the field of treatment has also extended from disease treatment to disease prevention. The main battlefield of its application has gradually shifted from medical institutions to communities. and family tilt.
脑超声波治疗是国内新兴的一种治疗技术,已经应用于神经系统疾病的临床治疗,尤其是应用于脑血管疾病的治疗,可有效的起到软化血管,改善脑组织供血,激活休眠的神经细胞,促进神经细胞功能分化和神经通路重建的作用,为治疗神经系统疾病提供了有利的手段。Brain ultrasound therapy is a new domestic treatment technology, which has been applied in the clinical treatment of nervous system diseases, especially in the treatment of cerebrovascular diseases, which can effectively soften blood vessels, improve blood supply to brain tissue, and activate dormant nerve cells , promote the functional differentiation of nerve cells and the reconstruction of neural pathways, and provide a favorable means for the treatment of nervous system diseases.
目前,尚无针对ND的弱激光和脑超声波治疗系统。At present, there is no low-level laser and brain ultrasound treatment system for ND.
发明内容Contents of the invention
本发明提供一种声光智能化无损骨传导治疗系统,用以克服现有技术中存在的至少一个技术问题。The invention provides an acousto-optic intelligent non-destructive bone conduction treatment system, which is used to overcome at least one technical problem existing in the prior art.
本发明实施例提供一种声光智能化无损骨传导治疗系统,所述系统包括:光声检测模块、处理模块、声疗模块和光疗模块;所述光声检测模块获取患者头部的第一超声信号和第二超声信号,将所述第一超声信号和所述第二超声信号发送给所述处理模块;其中,所述第一超声信号和所述第二超声信息为所述光疗模块的弱激光照射到患者头部的生物组织中时,由所述患者头部的生物组织的光吸收域所产生超声信号;所述第一超声信号和所述第二超声信号的获取时间间隔预设时间段;所述处理模块根据接收到的所述第一超声信号和所述第二超声信号,分别重建光声信号图像,生成所述患者的身体状态变化量;根据所述身体状态变化量、所述光疗模块的当前的光疗参数、所述声疗模块的当前的声疗参数、预设的光疗调整幅度和声疗调整幅度,生成新的光疗参数和新的声疗参数;将所述新的光疗参数和所述新的声疗参数分别发送给所述光疗模块和所述声疗模块;其中,所述光疗参数包括光照剂量,所述声疗参数包括超声功率;所述光疗模块根据接收到的所述新的光疗参数调整弱激光的光照剂量;所述声疗模块根据接收到的所述新的声疗参数调整超声波的超声功率。An embodiment of the present invention provides an acousto-optic intelligent non-destructive bone conduction therapy system, the system includes: a photoacoustic detection module, a processing module, a sound therapy module and a phototherapy module; the photoacoustic detection module acquires the first an ultrasonic signal and a second ultrasonic signal, sending the first ultrasonic signal and the second ultrasonic signal to the processing module; wherein, the first ultrasonic signal and the second ultrasonic information are information of the phototherapy module When the weak laser light is irradiated into the biological tissue of the patient's head, an ultrasonic signal is generated by the light absorption domain of the biological tissue of the patient's head; the acquisition time interval of the first ultrasonic signal and the second ultrasonic signal is preset time period; the processing module respectively reconstructs the photoacoustic signal image according to the received first ultrasonic signal and the second ultrasonic signal, and generates the patient's body state change amount; according to the body state change amount, The current phototherapy parameters of the phototherapy module, the current sound therapy parameters of the sound therapy module, the preset phototherapy adjustment range and the sound therapy adjustment range generate new phototherapy parameters and new sound therapy parameters; The phototherapy parameters and the new sound therapy parameters are sent to the phototherapy module and the sound therapy module respectively; wherein, the phototherapy parameters include light dose, and the sound therapy parameters include ultrasonic power; the phototherapy module receives The light dose of the weak laser is adjusted according to the received new phototherapy parameters; the sound therapy module adjusts the ultrasonic power of the ultrasonic waves according to the received new sound therapy parameters.
可选的,所述处理模块根据接收到的所述第一超声信号和所述第二超声信号,分别重建光声信号图像,生成所述患者的身体状态变化量的步骤,包括:所述根据所述身体状态变化量、所述光疗模块的当前的光疗参数、所述声疗模块的当前的声疗参数、预设的光疗调整幅度和声疗调整幅度,生成新的光疗参数和新的声疗参数的步骤,包括:所述处理模块根据患者的血液流速变化量、血氧含量变化量、脉搏变化量和治疗部位的温度变化量,计算当前的适应度值;所述处理模块根据所述适应度值和预设的适应度值分区表,判断所述当前的光疗参数和所述当前的声疗参数是否与所述患者匹配;若匹配,则所述处理模块基于所述当前的光疗参数,上调预设的光疗调整幅度,生成新的光疗参数,以及基于所述当前的声疗参数,上调预设的声疗调整幅度,生成新的声疗参数;若不匹配,则所述处理模块根据所述当前的光疗参数和预设的光疗调整幅度,下调光疗参数,生成新的光疗参数,以及根据所述当前的声疗参数和预设的声疗调整幅度,下调声疗参数,生成新的声疗参数所述处理模块根据所述第一超声信号和所述第二超声信号,分别重建第一光声信号图像和第二光声信号图像;根据所述第一光声信号图像和所述第二光声信号图像,生成所述患者的第一身体状态信息和第二身体状态信息,其中,所述第一身体状态信息和所述第二身体状态信息包括血液流速、血氧含量、脉搏和治疗部位的温度;所述处理模块根据所述第一身体状态信息和所述第二身体状态信息,生成所述患者的身体状态变化量;其中,所述身体状态变化量包括血液流速变化量、血氧含量变化量、脉搏变化量和治疗部位的温度变化量。Optionally, the processing module respectively reconstructs the photoacoustic signal image according to the received first ultrasonic signal and the second ultrasonic signal, and generates the step of changing the patient's physical state, including: The body state variation, the current phototherapy parameters of the phototherapy module, the current sound therapy parameters of the sound therapy module, the preset phototherapy adjustment range, and the sound therapy adjustment range generate new phototherapy parameters and new sound therapy parameters. The step of treating parameters includes: the processing module calculates the current fitness value according to the patient's blood flow rate variation, blood oxygen content variation, pulse variation and temperature variation of the treatment site; the processing module calculates the current fitness value according to the A fitness value and a preset fitness value partition table to determine whether the current phototherapy parameters and the current sound therapy parameters match the patient; if they match, the processing module based on the current phototherapy parameters , increase the preset adjustment range of phototherapy to generate new phototherapy parameters, and based on the current sound therapy parameters, increase the preset adjustment range of sound therapy to generate new sound therapy parameters; if they do not match, the processing module According to the current phototherapy parameters and the preset phototherapy adjustment range, the phototherapy parameters are lowered to generate new phototherapy parameters, and according to the current sound therapy parameters and the preset sound therapy adjustment range, the sound therapy parameters are lowered to generate new phototherapy parameters. The processing module reconstructs a first photoacoustic signal image and a second photoacoustic signal image according to the first ultrasonic signal and the second ultrasonic signal; according to the first photoacoustic signal image and the The second photoacoustic signal image to generate the first body state information and the second body state information of the patient, wherein the first body state information and the second body state information include blood flow rate, blood oxygen content, The pulse and the temperature of the treatment site; the processing module generates the change in the patient's body state according to the first body state information and the second body state information; wherein, the body state change includes a blood flow rate change blood oxygen level change, pulse rate change, and temperature change at the treatment site.
可选的,所述预设的适应度值分区表包括多个适应度值所在区间与评价的一一对应关系,所述评价包括适应、轻度不适应、不适应、严重不适应。Optionally, the preset fitness value partition table includes a one-to-one correspondence between multiple intervals of fitness values and evaluations, and the evaluations include adaptation, mild incompatibility, incompatibility, and severe incompatibility.
可选的,所述系统还包括声疗调整模块;所述声疗调整模块获取手动调整参数,将所述手动治疗参数发送给所述声疗模块;所述声疗模块根据接收到的所述手动调整参数调整超声波的超声功率。Optionally, the system further includes a sound therapy adjustment module; the sound therapy adjustment module acquires manual adjustment parameters, and sends the manual therapy parameters to the sound therapy module; Manually adjust the parameters to adjust the ultrasound power of the ultrasound.
本发明实施例的创新点包括:The innovations of the embodiments of the present invention include:
1、本发明提出的声光智能化无损骨传导治疗系统,可以使用弱激光和超声波对神经退行性疾病(NDs)的患者进行治疗,相对药物治疗,本发明的光疗和声疗对患者身体无任何副作用。是本发明实施例的创新点之一。1. The acousto-optic intelligent non-destructive bone conduction treatment system proposed by the present invention can use weak laser and ultrasonic waves to treat patients with neurodegenerative diseases (NDs). Compared with drug treatment, the phototherapy and sound therapy of the present invention have no effect on the patient's body. any side effects. It is one of the innovative points of the embodiment of the present invention.
2、本发明提出的声光智能化无损骨传导治疗系统,处理模块可以根据光声检测模块实时监控患者的身体状态,并根据患者当前的身体状态自动调节光疗模块和声疗模块的治疗参数,使用方便且安全可靠,无需具备专业技能,便于患者居家使用。是本发明实施例的创新点之一。2. In the acousto-optic intelligent non-destructive bone conduction treatment system proposed by the present invention, the processing module can monitor the patient's physical state in real time according to the photoacoustic detection module, and automatically adjust the treatment parameters of the phototherapy module and the sound therapy module according to the patient's current physical state, It is easy to use, safe and reliable, no professional skills are required, and it is convenient for patients to use at home. It is one of the innovative points of the embodiment of the present invention.
3、本发明提出的声光智能化无损骨传导治疗系统,处理模块可以根据患者当前时间段的身体状态,自动对弱激光的光照剂量和超声波的超声功率进行分阶段调整,避免出现由于光照剂量和/或超声功率过大造成患者身体不适,以及光照剂量和/或超声功率不足导致的治疗效果不佳等问题,兼顾患者体验感和治疗效果,以实现在患者体验较为舒适和安全的前提下,最大程度的提升治疗效果。是本发明实施例的创新点之一。3. In the acousto-optic intelligent non-destructive bone conduction therapy system proposed by the present invention, the processing module can automatically adjust the light dose of the weak laser and the ultrasonic power of the ultrasonic wave in stages according to the physical state of the patient at the current time period, so as to avoid the occurrence of the And/or excessive ultrasound power causes the patient's physical discomfort, as well as the poor treatment effect caused by insufficient light dose and/or ultrasound power, taking into account the patient's experience and treatment effect, so as to achieve a more comfortable and safe patient experience. , to maximize the therapeutic effect. It is one of the innovative points of the embodiment of the present invention.
4、本发明提出的声光智能化无损骨传导治疗系统,小巧便捷,可随身携带,适于家庭的日常护理治疗,可以像佩戴挂耳耳机一样佩戴在患者头部,患者在治疗过程可以自由行动,对患者的日常生活影响较小,有较佳的使用体验。是本发明实施例的创新点之一。4. The acousto-optic intelligent non-destructive bone conduction treatment system proposed by the present invention is small and convenient, can be carried around, and is suitable for daily care and treatment at home. It can be worn on the patient's head like wearing earphones, and the patient can freely during the treatment process. It has less impact on patients' daily life and has a better experience in use. It is one of the innovative points of the embodiment of the present invention.
附图说明Description of drawings
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the following will briefly introduce the drawings that need to be used in the description of the embodiments or the prior art. Obviously, the accompanying drawings in the following description are only These are some embodiments of the present invention. Those skilled in the art can also obtain other drawings based on these drawings without creative work.
图1为本发明提出的一种声光智能化无损骨传导治疗系统;Fig. 1 is an acousto-optic intelligent non-destructive bone conduction therapy system proposed by the present invention;
图2为本发明提出的另一种声光智能化无损骨传导治疗系统;Fig. 2 is another acousto-optic intelligent non-destructive bone conduction therapy system proposed by the present invention;
图3为本发明中步骤213的具体处理流程图;Fig. 3 is the specific processing flowchart of
图4为本发明提出的一种挂耳式声光智能化无损骨传导治疗仪;Fig. 4 is an ear-mounted acousto-optic intelligent non-destructive bone conduction therapeutic instrument proposed by the present invention;
图5为本发明提出的一种挂耳式声光智能化无损骨传导治疗仪和远程操作终端。Fig. 5 is an ear-mounted acousto-optic intelligent non-destructive bone conduction therapy instrument and a remote operation terminal proposed by the present invention.
具体实施方式Detailed ways
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有付出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some, not all, embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.
需要说明的是,本发明实施例及附图中的术语“包括”和“具有”以及它们任何变形,意图在于覆盖不排他的包含。例如包含了一系列步骤或单元的过程、方法、系统、产品或设备没有限定于已列出的步骤或单元,而是可选地还包括没有列出的步骤或单元,或可选地还包括对于这些过程、方法、产品或设备固有的其它步骤或单元。It should be noted that the terms "include" and "have" and any variations thereof in the embodiments of the present invention and drawings are intended to cover non-exclusive inclusion. For example, a process, method, system, product or device comprising a series of steps or units is not limited to the listed steps or units, but optionally also includes unlisted steps or units, or optionally further includes For other steps or units inherent in these processes, methods, products or apparatuses.
本发明提出了一种声光智能化无损骨传导治疗系统,参考图1,图1为本发明提出的一种声光智能化无损骨传导治疗系统。如图1所示,声光智能化无损骨传导治疗系统包括:光声检测模块、处理模块、声疗模块和光疗模块。系统中各模块的交互流程如下:The present invention proposes an acousto-optic intelligent non-destructive bone conduction treatment system, refer to FIG. 1 , which is an acousto-optic intelligent non-destructive bone conduction treatment system proposed by the present invention. As shown in Figure 1, the acousto-optic intelligent nondestructive bone conduction therapy system includes: a photoacoustic detection module, a processing module, an acoustic therapy module and a phototherapy module. The interaction process of each module in the system is as follows:
步骤101,所述光声检测模块获取患者头部的第一超声信号和第二超声信号,将所述第一超声信号和所述第二超声信号发送给所述处理模块。
其中,所述第一超声信号和所述第二超声信息为所述光疗模块的弱激光照射到患者头部的生物组织中时,由所述患者头部的生物组织的光吸收域所产生超声信号;所述第一超声信号和所述第二超声信号的获取时间间隔预设时间段。Wherein, the first ultrasonic signal and the second ultrasonic information are ultrasonic waves generated by the light absorption domain of the biological tissue of the patient's head when the weak laser light of the phototherapy module is irradiated into the biological tissue of the patient's head. signal; the acquisition time interval of the first ultrasonic signal and the second ultrasonic signal is a preset time period.
在本步骤中,光声检测模块可以获取患者的第一超声信号和第二超声信息,其中,第一超声信息的获取时间与第二超声信息的获取时间可以间隔预设时间段,预设时间段可以为10-100μs,第一超声信息和第二超声信息可以反应附近时间段内患者身体的变化情况,为后续步骤判断光疗和声疗的治疗参数是否合适提供参考。In this step, the photoacoustic detection module can acquire the first ultrasound signal and the second ultrasound information of the patient, wherein the acquisition time of the first ultrasound information and the acquisition time of the second ultrasound information can be separated by a preset time period, and the preset time The interval can be 10-100μs. The first ultrasound information and the second ultrasound information can reflect the changes of the patient's body in the nearby time period, and provide a reference for the subsequent steps to judge whether the treatment parameters of phototherapy and sound therapy are appropriate.
步骤103,所述处理模块根据接收到的所述第一超声信号和所述第二超声信号,分别重建光声信号图像,生成所述患者的身体状态变化量。
在本步骤中,处理模块可以根据光声检测模块发送的第一超声信号和第二超声信号,生成反应患者当前对光疗和声疗治疗效果反应程度的身体状态变化量,达到实时监控患者身体状态的目的。In this step, the processing module can generate a body state change that reflects the patient's current response to phototherapy and sound therapy according to the first ultrasonic signal and the second ultrasonic signal sent by the photoacoustic detection module, so as to achieve real-time monitoring of the patient's physical state the goal of.
需要说明的是,所述第一超声信号和所述第二超声信息为所述光疗模块的弱激光照射到患者头部的生物组织中时,由所述患者头部的生物组织的光吸收域所产生超声信号;所述处理模块根据第一超声信号和第二超声信号,可以分别重建两张光声信号图像,通过两张光声信号图像,可以体现患者在最近一段时间内血液流速、血氧含量、脉搏和治疗部位的温度等身体关键参数的变化情况。It should be noted that the first ultrasonic signal and the second ultrasonic information are when the weak laser light of the phototherapy module is irradiated into the biological tissue of the patient's head, the light absorption domain of the biological tissue of the patient's head Generated ultrasonic signals; the processing module can respectively reconstruct two photoacoustic signal images according to the first ultrasonic signal and the second ultrasonic signal, and through the two photoacoustic signal images, it can reflect the patient's blood flow rate, blood oxygen content, pulse Changes in key parameters of the body such as temperature and temperature of the treatment area.
如果身体状态变化量较大,可以说明患者可能不适应当前的光疗和声疗强度,也可能已出现较为严重过敏反应,可以通过后续步骤及时修改治疗参数降低治疗强度,或者停止治疗,避免对身体继续造成伤害。如果身体状态变化量在合理范围内,可以说明患者较为适应当前的治疗强度,可以进一步增大治疗参数,以提高治疗效果。If the physical state changes greatly, it can indicate that the patient may not adapt to the current intensity of phototherapy and sound therapy, or may have experienced a relatively severe allergic reaction. The subsequent steps can be followed to modify the treatment parameters in time to reduce the treatment intensity, or stop the treatment to avoid damage to the body. Continue to cause damage. If the amount of change in physical state is within a reasonable range, it can indicate that the patient is more suitable for the current treatment intensity, and the treatment parameters can be further increased to improve the treatment effect.
步骤105,所述处理模块根据所述身体状态变化量、所述光疗模块的当前的光疗参数、所述声疗模块的当前的声疗参数、预设的光疗调整幅度和声疗调整幅度,生成新的光疗参数和新的声疗参数;将所述新的光疗参数和所述新的声疗参数分别发送给所述光疗模块和所述声疗模块。
其中,所述光疗参数包括光照剂量,所述声疗参数包括超声功率。Wherein, the phototherapy parameters include light dose, and the sound therapy parameters include ultrasonic power.
在本步骤中,处理模块可以根据生成的身体状态变化量,确定当前的光疗参数和当前的声疗参数对患者是否合适。In this step, the processing module can determine whether the current phototherapy parameters and the current sound therapy parameters are suitable for the patient according to the generated body state variation.
若合适,则可以根据预设的光疗调整幅度和预设的声疗调整幅度,在当前的光疗参数和当前的声疗参数的基础上,上调各项治疗参数,提高治疗效果。If appropriate, according to the preset adjustment range of phototherapy and the preset adjustment range of sound therapy, on the basis of the current phototherapy parameters and the current sound therapy parameters, various treatment parameters can be adjusted up to improve the treatment effect.
若不合适,则可以根据预设的光疗调整幅度和预设的声疗调整幅度,在当前的光疗参数和当前的声疗参数的基础上,下调各项治疗参数,得到与患者当前状态匹配的新的光疗参数和新的声疗参数,并且将新的光疗参数和新的声疗参数分别发送给光疗模块和声疗模块,以便光疗模块和声疗及时调整光照剂量和超声功率。一方面,在患者的身体可以接受的前提下,提高光照剂量和超声功率,增进治疗效果,另一方面,若患者出现不适反应,则可以及时降低光照剂量和超声功率甚至停止治疗,以保证患者的身体安全。If it is not suitable, according to the preset phototherapy adjustment range and the preset sound therapy adjustment range, on the basis of the current phototherapy parameters and the current sound therapy parameters, various treatment parameters can be lowered to obtain a treatment that matches the current state of the patient. new phototherapy parameters and new sound therapy parameters, and send the new phototherapy parameters and new sound therapy parameters to the phototherapy module and the sound therapy module respectively, so that the phototherapy module and the sound therapy module can adjust the light dose and ultrasonic power in time. On the one hand, on the premise that the patient's body can accept it, increase the light dose and ultrasonic power to improve the therapeutic effect; on the other hand, if the patient has an uncomfortable reaction, the light dose and ultrasonic power can be reduced in time or even stop the treatment to ensure the patient's health. body safety.
需要说明的是,光疗参数可以包括光照功率、光照频率等能够影响光疗模块的光照剂量的参数。It should be noted that the phototherapy parameters may include parameters such as light power and light frequency that can affect the light dose of the phototherapy module.
在具体实施中,为了保证治疗效果,声疗模块的超声波需要作用于所述患者的耳后颅骨,光疗模块的弱激光需要作用于所述患者的脑中缝的脑膜淋巴管。In specific implementation, in order to ensure the therapeutic effect, the ultrasonic wave of the sound therapy module needs to act on the skull behind the ear of the patient, and the weak laser light of the phototherapy module needs to act on the meningeal lymphatic vessels of the patient's brain suture.
步骤107,所述光疗模块根据接收到的所述新的光疗参数调整弱激光的光照剂量;所述声疗模块根据接收到的所述新的声疗参数调整超声波的超声功率。
在本步骤中,光疗模块可以根据处理模块发送的新的光疗参数,调整治疗光照剂量,声疗模块可以根据处理模块发送的新的声疗参数,调整超声功率,以使弱激光的光照剂量和超声波的超声功率与患者身体状态相适应,避免出现身体不适,提升患者的使用体验。In this step, the phototherapy module can adjust the treatment light dose according to the new phototherapy parameters sent by the processing module, and the sound therapy module can adjust the ultrasonic power according to the new sound therapy parameters sent by the processing module, so that the light dose of the weak laser and The ultrasound power of the ultrasound is adapted to the patient's physical state, avoiding physical discomfort and improving the patient's experience.
可见,本发明提出的声光智能化无损骨传导治疗系统,相对药物治疗,本发明的光疗和声疗对患者身体无任何副作用;此外,处理模块可以通过光声检测模块实时监测患者的身体状态并根据患者当前的身体状态自动调节光疗模块的光照剂量和声疗模块的超声功率,使用方便且安全可靠,无需具备专业技能,便于患者居家使用,并且可以提升患者的使用体验,以及小巧便捷,可随身携带,适于家庭的日常护理治疗。It can be seen that the acousto-optic intelligent non-destructive bone conduction treatment system proposed by the present invention, compared with drug treatment, the phototherapy and sound therapy of the present invention have no side effects on the patient's body; in addition, the processing module can monitor the patient's physical state in real time through the photoacoustic detection module And according to the current physical state of the patient, the light dose of the phototherapy module and the ultrasonic power of the sound therapy module are automatically adjusted. It is easy to use, safe and reliable, and does not require professional skills. It is convenient for patients to use at home, and can improve the patient's experience. Portable, suitable for daily care and treatment at home.
本发明还提出另一种声光智能化无损骨传导治疗系统,参考图2,图2为本发明提出的另一种声光智能化无损骨传导治疗系统。如图2所示,另一种声光智能化无损骨传导治疗系统的处理步骤如下:The present invention also proposes another acousto-optic intelligent non-destructive bone conduction therapy system, refer to FIG. 2 , which is another acousto-optic intelligent non-destructive bone conduction therapy system proposed by the present invention. As shown in Figure 2, the processing steps of another acousto-optic intelligent nondestructive bone conduction therapy system are as follows:
步骤201,所述光声检测模块获取患者头部的第一超声信号和第二超声信号,将所述第一超声信号和所述第二超声信号发送给所述处理模块。
本步骤的具体实现过程可以参考图1所示的一种声光智能化无损骨传导治疗系统的步骤101中的相关说明,在此不再赘述。For the specific implementation process of this step, reference may be made to the relevant description in
步骤203,所述处理模块根据所述第一超声信号和所述第二超声信号,分别重建第一光声信号图像和第二光声信号图像;根据所述第一光声信号图像和所述第二光声信号图像,生成所述患者的第一身体状态信息和第二身体状态信息。
其中,所述第一身体状态信息和所述第二身体状态信息包括血液流速、血氧含量、脉搏和治疗部位的温度。Wherein, the first body state information and the second body state information include blood flow rate, blood oxygen content, pulse and temperature of the treatment site.
在本步骤中,处理模块可以根据监控模块发送的第一超声信号,通过数据直线反投影算法重建光声信号图像,得到第一光声信号图像,进而基于第一光声信号图像,根据图像处理程序,得到血液流速、血氧含量、脉搏和治疗部位的温度等参数,生成所述患者的第一身体状态信息,以及可以根据监控模块发送的第二超声信号,通过数据直线反投影算法重建光声信号图像,得到第二光声信号图像,进而生成所述患者的第二身体状态信息。In this step, the processing module can reconstruct the photoacoustic signal image through the data linear back projection algorithm according to the first ultrasonic signal sent by the monitoring module to obtain the first photoacoustic signal image, and then based on the first photoacoustic signal image, according to the image processing The program obtains parameters such as blood flow rate, blood oxygen content, pulse and temperature of the treatment site, generates the first body state information of the patient, and can reconstruct the light through the data linear back projection algorithm according to the second ultrasonic signal sent by the monitoring module. The acoustic signal image is obtained to obtain a second photoacoustic signal image, and then second body state information of the patient is generated.
可以理解的,第一身体状态信息和第二身体状态信息,能够体现患者在近期一段时间内的身体状态。第一身体状态信息和第二身体状态信息不局限于血液流速、血氧含量、脉搏和治疗部位的温度,可以根据实际情况,添加其他能够体现身体状态的且能够从光声信号图像中获取的参数。It can be understood that the first physical state information and the second physical state information can reflect the physical state of the patient in a recent period of time. The first body state information and the second body state information are not limited to blood flow rate, blood oxygen content, pulse and temperature of the treatment site, and other information that can reflect the body state and can be obtained from the photoacoustic signal image can be added according to the actual situation. parameter.
步骤205,所述处理模块根据所述第一身体状态信息和所述第二身体状态信息,生成所述患者的身体状态变化量。In
其中,所述身体状态变化量包括血液流速变化量、血氧含量变化量、脉搏变化量和治疗部位的温度变化量。Wherein, the body state variation includes blood flow velocity variation, blood oxygen content variation, pulse variation and temperature variation of the treatment site.
在本步骤中,处理模块可以根据第一身体状态信息和第二身体状态信息,计算患者的身体状态变化量,以根据身体状态变化量判断患者最近一段时间内的身体状态与光疗和声疗的治疗强度是否匹配。In this step, the processing module can calculate the patient's body state change amount according to the first body state information and the second body state information, so as to judge the relationship between the patient's body state in the latest period of time and the phototherapy and sound therapy according to the body state change amount. Does the treatment intensity match.
步骤207,所述处理模块根据患者的血液流速变化量、血氧含量变化量、脉搏变化量和治疗部位的温度变化量,计算当前的适应度值。
在本步骤中,处理模块可以根据患者的血液流速变化量、血氧含量变化量、脉搏变化量和治疗部位的温度变化量,计算当前的适应度值。In this step, the processing module can calculate the current fitness value according to the patient's blood flow velocity variation, blood oxygen content variation, pulse variation and temperature variation of the treatment site.
具体的,计算适应度值的的公式如下所示:Specifically, the formula for calculating the fitness value is as follows:
x=40%·a+40%·b+10%·c+10%·d(1)x=40%·a+40%·b+10%·c+10%·d(1)
在公式(1)中,a为血液流速变化量,b为血氧含量变化量,c为脉搏变化量,d为治疗部位的温度变化量。In the formula (1), a is the variation of the blood flow velocity, b is the variation of the blood oxygen content, c is the variation of the pulse, and d is the variation of the temperature of the treatment site.
需要说明的是,各变化量对应的权重值,比如在公式(1)中血液流速变化量对应的40%权重值,血氧含量变化量对应的40%权重值,脉搏变化量对应的10%权重值和治疗部位的温度变化量对应的10%权重值,均可以根据实际情况来调整。It should be noted that the weight values corresponding to each change amount, such as the 40% weight value corresponding to the blood flow velocity change amount in formula (1), the 40% weight value corresponding to the blood oxygen content change amount, and the 10% weight value corresponding to the pulse change amount Both the weight value and the 10% weight value corresponding to the temperature variation of the treatment site can be adjusted according to the actual situation.
步骤209,所述处理模块根据所述适应度值和预设的适应度值分区表,判断所述当前的光疗参数和所述当前的声疗参数是否与所述患者匹配;若匹配,则执行步骤211,若不匹配,则执行步骤213。
在本步骤中,处理模块可以根据计算出的适应度值,在预设的适应度值分区表中进行查询,根据查询结果判断光疗模块和声疗模块的当前治疗参数,是否与患者的身体状态相匹配。若匹配,则执行步骤207,以便及时增大光照剂量和超声功率,提高治疗效果,若不匹配,则执行步骤209,以及时降低光照剂量和/或超声功率,避免对患者身体造成损伤。In this step, the processing module can query the preset fitness value partition table according to the calculated fitness value, and judge whether the current treatment parameters of the phototherapy module and the sound therapy module are consistent with the patient's physical state according to the query results. match. If they match, go to step 207 to increase the light dose and ultrasound power in time to improve the treatment effect; if not, go to step 209 to reduce the light dose and/or ultrasound power in time to avoid damage to the patient's body.
在本步骤中,处理模块可以根据计算出的适应度值,在预设的适应度值分区表中找到与适应度值对应的评价,以进一步确定与患者身体相匹配的处理方式。In this step, the processing module can find the evaluation corresponding to the fitness value in the preset fitness value partition table according to the calculated fitness value, so as to further determine the treatment method that matches the patient's body.
可选的,所述预设的适应度值分区表可以包括多个适应度值所在区间与评价的一一对应关系,所述评价可以包括适应、轻度不适应、不适应、严重不适应和过敏。具体的,预设的适应度值分区表可以如表1所示。Optionally, the preset fitness value partition table may include a one-to-one correspondence between multiple intervals of fitness values and evaluations, and the evaluations may include adaptation, mild discomfort, incompatibility, severe incompatibility and allergy. Specifically, the preset fitness value partition table may be as shown in Table 1.
表1Table 1
当然,在实际应用中,可以根据患者的身体情况,设置预设的适应度值分区表。Of course, in practical applications, a preset fitness value partition table can be set according to the physical condition of the patient.
步骤211,所述处理模块基于所述当前的光疗参数,上调预设的光疗调整幅度,生成新的光疗参数,以及基于所述当前的声疗参数,上调预设的声疗调整幅度,生成新的声疗参数。
在本步骤中,由于光疗模块当前的光疗参数和声疗模块当前的声疗参数,与患者的身体状态相匹配,因此,可以上调预设的光疗调整幅度和预设的声疗调整幅度,生成新的光疗参数和新的声疗参数,以及将新的光疗参数和新的声疗参数分别发送给所述光疗模块和声疗模块,这样可以在患者的身体舒适的前提下,及时增大光疗模块的光照剂量和声疗模块的超声功率,以提高治疗效果。In this step, since the current phototherapy parameters of the phototherapy module and the current sound therapy parameters of the sound therapy module match the physical state of the patient, the preset phototherapy adjustment range and the preset sound therapy adjustment range can be adjusted up to generate New phototherapy parameters and new sound therapy parameters, and sending the new phototherapy parameters and new sound therapy parameters to the phototherapy module and the sound therapy module respectively, so that the phototherapy parameters can be increased in time while the patient's body is comfortable. The light dose of the module and the ultrasonic power of the sound therapy module to improve the treatment effect.
通常情况下,预设的光疗调整幅度和预设的声疗调整幅度可以在10-40HZ范围内选择,预设的光疗调整幅度和预设的声疗调整幅度可以相同,也可以不同,具体可以根据实际情况来确定。Normally, the preset light therapy adjustment range and the preset sound therapy adjustment range can be selected within the range of 10-40HZ. The preset light therapy adjustment range and the preset sound therapy adjustment range can be the same or different, and the details can be Determine according to the actual situation.
步骤213,所述处理模块根据所述当前的光疗参数和预设的光疗调整幅度,下调光疗参数,生成新的光疗参数,以及根据所述当前的声疗参数和预设的声疗调整幅度,下调声疗参数,生成新的声疗参数。
在本步骤中,由于光疗模块当前的光疗参数和声疗模块当前的声疗参数,与患者的治疗部位状态不匹配,因此,可以基于当前的光疗参数和当前的声疗参数,分别对光照剂量和超声功率下调预设的调整幅度,生成新的光疗参数和新的声疗参数,以及将新的光疗参数和新的声疗参数分别发送给所述光疗模块和声疗模块,以缓解患者身体状态,避免对患者身体造成损伤,提升患者的使用体验。In this step, since the current phototherapy parameters of the phototherapy module and the current sound therapy parameters of the sound therapy module do not match the status of the patient's treatment site, the light dose can be adjusted based on the current phototherapy parameters and the current sound therapy parameters. and the ultrasonic power down-regulate the preset adjustment range, generate new phototherapy parameters and new sound therapy parameters, and send the new phototherapy parameters and new sound therapy parameters to the phototherapy module and the sound therapy module respectively, so as to relieve the patient's body state, avoiding damage to the patient's body, and improving the patient's experience.
可选的,参考图3,图3为本发明中步骤213的具体处理流程图,如图3所示,步骤213具体可以包括:Optionally, refer to FIG. 3. FIG. 3 is a specific processing flowchart of
子步骤31,若所述适应度值在所述预设的适应度值分区表中的评价为轻度不适应,则确定实际光疗下调幅度为一倍的预设的光疗调整幅度,实际声疗下调幅度为一倍的预设的声疗调整幅度;若所述适应度值在所述预设的适应度值分区表中的评价为不适应,则确定实际光疗下调幅度为两倍的预设的光疗调整幅度,实际声疗下调幅度为两倍的预设的声疗调整幅度;若所述适应度值在所述预设的适应度值分区表中的评价为严重不适应,则确定实际光疗下调幅度为三倍的预设的光疗调整幅度,实际声疗下调幅度为三倍的预设的声疗调整幅度。Sub-step 31, if the evaluation of the fitness value in the preset fitness value partition table is mild discomfort, then determine that the actual phototherapy down-regulation range is double the preset phototherapy adjustment range, and the actual sound therapy The preset sound therapy adjustment range is doubled; if the fitness value is evaluated as unsuitable in the preset fitness value partition table, it is determined that the actual phototherapy reduction range is twice the preset The adjustment range of phototherapy, the actual sound therapy down-regulation range is twice the preset sound therapy adjustment range; The light therapy reduction range is three times the preset light therapy adjustment range, and the actual sound therapy reduction range is three times the preset sound therapy adjustment range.
子步骤32,在所述当前的光疗参数和当前的声疗参数的基础上,下调所述实际光疗下调幅度和所述声疗下调幅度,生成新的光疗参数和新的声疗参数。Sub-step 32, on the basis of the current phototherapy parameters and the current sound therapy parameters, down-regulate the actual phototherapy down-regulation range and the sound therapy down-regulation range to generate new phototherapy parameters and new sound therapy parameters.
具体的,在当前的光照剂量和当前的超声功率与患者不匹配的情况下,更加细化下调光照剂量和超声功率的实现方式,分阶段下调光照剂量和超声功率,评价较轻的,光照剂量和超声功率的下调幅度较小,评价较严重的,光照剂量和超声功率的下调幅度较大。在对患者身体不造成损伤的情况下,尽量保证光疗模块和声疗模块的治疗效果。Specifically, in the case that the current light dose and current ultrasound power do not match the patient, the implementation method of reducing the light dose and ultrasound power is more detailed, and the light dose and ultrasound power are lowered in stages. If the evaluation is lighter, the light dose The reduction range of radiation dose and ultrasound power is small, and the reduction range of light dose and ultrasound power is relatively large for those with serious evaluation. In the case of not causing damage to the patient's body, try to ensure the therapeutic effect of the phototherapy module and the sound therapy module.
可选的,所述评价还可以包括过敏;Optionally, the evaluation may also include allergies;
若评价为过敏,或所述身体状态变化量中至少一项变化量超过预设区间,则所述处理模块向所述光疗模块和所述声疗模块发送停止治疗指令;If it is evaluated as allergic, or at least one of the changes in the physical state exceeds a preset interval, the processing module sends an instruction to stop treatment to the phototherapy module and the sound therapy module;
所述光疗模块和所述声疗模块在接收到所述停止治疗指令后,分别停止光疗和声疗。The light therapy module and the sound therapy module stop the light therapy and the sound therapy respectively after receiving the instruction to stop the therapy.
具体的,当适应度值在预设的适应度值分区表中对应的评价为过敏时,说明患者的治疗部位已经出现过敏状态,或者在第二身体状态信息中的血液流速、血氧含量、脉搏和治疗部位的温度中至少一项超过预设区间时,处理模块立刻向所述光疗模块发送停止治疗指令,光疗模块在接收到所述停止治疗指令后,关闭所述治疗光源,以避免加重患者治疗部位的过敏情况。Specifically, when the fitness value is evaluated as allergic in the preset fitness value partition table, it indicates that the patient's treatment site has already appeared in an allergic state, or the blood flow rate, blood oxygen content, When at least one of the pulse and the temperature of the treatment site exceeds the preset range, the processing module immediately sends a treatment stop instruction to the phototherapy module, and the phototherapy module turns off the treatment light source after receiving the treatment stop instruction to avoid aggravating Hypersensitivity to the treatment site in the patient.
具体的,治疗部位的温度的预设区间可以为36.2℃-40℃,当治疗部位的温度超过40℃时,处理模块向光疗模块和声疗模块发送停止治疗指令;血氧含量的预设区间可以为95%-100%,当血氧含量低于95%时,处理模块向光疗模块和声疗模块发送停止治疗指令;脉搏的预设区间可以为60-120次/分,当脉搏超过120次/分时,处理模块向光疗模块和声疗模块发送停止治疗指令;血液流速的预设区间可以为616-781mL/min,当血液流速超过781mL/min时,处理模块向光疗模块和声疗模块发送停止治疗指令。Specifically, the preset range of the temperature of the treatment site can be 36.2°C-40°C. When the temperature of the treatment site exceeds 40°C, the processing module sends an order to stop the treatment to the phototherapy module and the sound therapy module; the preset range of the blood oxygen content It can be 95%-100%. When the blood oxygen content is lower than 95%, the processing module sends an instruction to stop treatment to the phototherapy module and the sound therapy module; the preset interval of the pulse can be 60-120 beats/min. Time/minute, the processing module sends a stop treatment command to the phototherapy module and the sound therapy module; the preset range of blood flow rate can be 616-781mL/min, when the blood flow rate exceeds 781mL/min, the processing module sends a message to the phototherapy module and sound therapy module The module sends a command to stop therapy.
在具体实施中,所述系统还包括声疗调整模块;In a specific implementation, the system also includes a sound therapy adjustment module;
所述声疗调整模块获取手动调整参数,将所述手动治疗参数发送给所述声疗模块;所述声疗模块根据接收到的所述手动调整参数调整超声波的超声功率。The sound therapy adjustment module acquires manual adjustment parameters, and sends the manual treatment parameters to the sound therapy module; the sound therapy module adjusts the ultrasonic power of the ultrasonic waves according to the received manual adjustment parameters.
具体的,在部分场景下,可以通过患者手动通过调整声疗调整模块,调节声疗模块的功率参数,由声疗调整模块将手动调整参数发送给声疗模块,以便声疗模块按照手动调整参数调整超声功率。Specifically, in some scenarios, the patient can manually adjust the power parameters of the sound therapy module by adjusting the sound therapy adjustment module, and the sound therapy adjustment module will send the manually adjusted parameters to the sound therapy module, so that the sound therapy module can manually adjust the parameters. Adjust the ultrasound power.
可见,本发明提出的另一种声光智能化无损骨传导治疗系统,处理模块可以根据患者当前时间段的治疗部位信息,自动对光疗模块的光照剂量进行分阶段调整,避免出现由于光照剂量较大造成的患者治疗部位不适,以及光照剂量不足导致的治疗效果不佳等问题,兼顾患者体验感和治疗效果,以实现在患者治疗部位较为舒适的前提下,最大程度的提升治疗效果。It can be seen that in another acousto-optic intelligent non-destructive bone conduction treatment system proposed by the present invention, the processing module can automatically adjust the light dose of the phototherapy module in stages according to the treatment site information of the patient in the current time period, so as to avoid the occurrence of light dose due to low light dose. The discomfort caused by the patient's treatment site and the poor treatment effect caused by insufficient light dose are taken into account. The patient's experience and treatment effect are taken into account, so as to achieve the maximum improvement of the treatment effect on the premise that the patient's treatment site is more comfortable.
在具体实施中,本发明又提出一种挂耳式声光智能化无损骨传导治疗仪。参考图4,图4为本发明提出的一种挂耳式声光智能化无损骨传导治疗仪。In specific implementation, the present invention further proposes an ear-mounted acousto-optic intelligent non-destructive bone conduction therapeutic instrument. Referring to Fig. 4, Fig. 4 is an ear-mounted acousto-optic intelligent non-destructive bone conduction therapeutic instrument proposed by the present invention.
如图4所示,所述声疗模块401设置在所述治疗仪40的侧端,以使患者佩戴所述治疗仪后,所述声疗模块401的超声波作用于所述患者的耳后颅骨;所述光疗模块402设置在所述治疗仪的后端,以使患者佩戴所述治疗仪后,所述光疗模块402的弱激光作用于所述患者的脑中缝的脑膜淋巴管;As shown in Figure 4, the
所述光声检测模块403与所述光疗模块402设置在同一位置,或者光疗模块402能够同时实现光声检测模块和光疗模块的功能。The photoacoustic detection module 403 and the
所述处理模块为微型处理器404,设置在所述治疗仪的任一处。The processing module is a
所述声疗模块401设置在所述治疗仪的一侧端,所述声疗调整模块405设置所述另一侧端,所述声疗调整模块405包括用于提高超声功率的增量按键和用于降低超声功率的减量按键。The
具体的,挂耳式声光智能化无损骨传导治疗仪40内部模块的交互流程如下:Specifically, the interaction process of the internal modules of the ear-mounted acousto-optic intelligent non-destructive bone
所述光声检测模块403获取患者头部的第一超声信号和第二超声信号,将所述第一超声信号和所述第二超声信号发送给所述处理模块404;其中,所述第一超声信号和所述第二超声信息为所述光疗模块的弱激光照射到患者头部的生物组织中时,由所述患者头部的生物组织的光吸收域所产生超声信号;所述第一超声信号和所述第二超声信号的获取时间间隔预设时间段。The photoacoustic detection module 403 acquires the first ultrasonic signal and the second ultrasonic signal of the patient's head, and sends the first ultrasonic signal and the second ultrasonic signal to the
所述处理模块404根据接收到的所述第一超声信号和所述第二超声信号,分别重建光声信号图像,生成所述患者的身体状态变化量;根据所述身体状态变化量、所述光疗模块的当前的光疗参数、所述声疗模块的当前的声疗参数、预设的光疗调整幅度和声疗调整幅度,生成新的光疗参数和新的声疗参数;将所述新的光疗参数和所述新的声疗参数分别发送给所述光疗模块402和所述声疗模块401;其中,所述光疗参数包括光照剂量,所述声疗参数包括超声功率。The
所述光疗模块402根据接收到的所述新的光疗参数调整弱激光的光照剂量;所述声疗模块401根据接收到的所述新的声疗参数调整超声波的超声功率。The
此外,还可以在治疗仪40中设置两个耳机406,在治疗过程中,患者可以听歌曲放松心情。In addition, two
处理方法中的具体细节可以参考前文实施例,在此不再赘述。For specific details in the processing method, reference may be made to the foregoing embodiments, and details are not repeated here.
在本实施例中,挂耳式声光智能化无损骨传导治疗仪能够解决目前治疗仪治疗时无法实时监控治疗过程的问题,可以实时监控患者身体状态,以自适应调节光治疗剂量。此外,挂耳式声光智能化无损骨传导治疗仪具有操作自由性,在不影响治疗效果的前提下,患者在接受治疗的同时可以做其他事情,使用方便安全,适用于居家的日常护理。In this embodiment, the ear-mounted acousto-optic intelligent non-destructive bone conduction therapeutic instrument can solve the problem that the current therapeutic instrument cannot monitor the treatment process in real time, and can monitor the patient's physical condition in real time to adaptively adjust the phototherapy dose. In addition, the ear-mounted acousto-optic intelligent non-destructive bone conduction therapy instrument has the freedom of operation. Without affecting the treatment effect, patients can do other things while receiving treatment. It is convenient and safe to use, and is suitable for daily care at home.
在具体实施中,本发明再提出一种声光智能化无损骨传导治疗系统,具体包括挂耳式声光智能化无损骨传导治疗仪和远程操作终端。参考图5,图5为本发明提出的一种挂耳式声光智能化无损骨传导治疗仪和远程操作终端。In specific implementation, the present invention further proposes an acousto-optic intelligent non-destructive bone conduction treatment system, which specifically includes an ear-mounted acousto-optic intelligent non-destructive bone conduction treatment instrument and a remote operation terminal. Referring to Fig. 5, Fig. 5 shows an ear-mounted acousto-optic intelligent non-destructive bone conduction therapy instrument and a remote operation terminal proposed by the present invention.
如图5所示,所述挂耳式声光智能化无损骨传导治疗仪60中,所述声疗模块601设置在所述治疗仪60的两侧端,以使患者佩戴所述治疗仪后,所述声疗模块601的超声波作用于所述患者的耳后颅骨。As shown in Figure 5, in the ear-mounted acousto-optic intelligent non-destructive bone conduction
所述光疗模块602设置在所述治疗仪的后端,以使患者佩戴所述治疗仪后,所述光疗模块602的弱激光作用于所述患者的脑中缝的脑膜淋巴管。The
所述光声检测模块603与所述光疗模块602设置在同一位置,或者光疗模块602能够同时实现光声检测模块和光疗模块的功能。The photoacoustic detection module 603 and the
所述声疗调整模块604设置在所述治疗仪60的一侧端,所述声疗调整模块604包括用于提高超声功率的增量按键和用于降低超声功率的减量按键。The sound
需要说明的是,所述声疗调整模块604与所述声疗模块601互不影响。It should be noted that the sound
所述挂耳式声光智能化无损骨传导治疗仪60还包括第一通信模块605。The ear-mounted acousto-optic intelligent non-destructive bone
所述远程操作终端50中设置有所述处理模块501、所述调整模块502和第二通信模块502。The
所述调整模块502用于调整所述光疗模块602的光照剂量以及所述声疗模块604的超声功率;The
所述挂耳式声光智能化无损骨传导治疗仪60和所述远程操作终端50分别通过所述第一通信模块605和所述第二通信模块502连接。The ear-mounted acousto-optic intelligent nondestructive bone
具体的,挂耳式声光智能化无损骨传导治疗仪60和远程操作终端50的交互流程如下:Specifically, the interaction process between the ear-mounted acousto-optic intelligent non-destructive bone
所述光声检测模块603获取患者头部的第一超声信号和第二超声信号,将所述第一超声信号和所述第二超声信号通过第一通信模块605,发送给第二通信模块502,由第二通信模块502发送给所述处理模块501;其中,所述第一超声信号和所述第二超声信息为所述光疗模块的弱激光照射到患者头部的生物组织中时,由所述患者头部的生物组织的光吸收域所产生超声信号;所述第一超声信号和所述第二超声信号的获取时间间隔预设时间段。The photoacoustic detection module 603 acquires the first ultrasonic signal and the second ultrasonic signal of the patient's head, and sends the first ultrasonic signal and the second ultrasonic signal to the
所述处理模块404根据接收到的所述第一超声信号和所述第二超声信号,分别重建光声信号图像,生成所述患者的身体状态变化量;根据所述身体状态变化量、所述光疗模块的当前的光疗参数、所述声疗模块的当前的声疗参数、预设的光疗调整幅度和声疗调整幅度,生成新的光疗参数和新的声疗参数;将所述新的光疗参数和所述新的声疗参数通过第二通信模块502发送到第一通信模块605,由第一通信模块605分别发送给所述光疗模块402和所述声疗模块401;其中,所述光疗参数包括光照剂量,所述声疗参数包括超声功率。The
所述光疗模块402根据接收到的所述新的光疗参数调整弱激光的光照剂量;所述声疗模块401根据接收到的所述新的声疗参数调整超声波的超声功率。The
需要说明的是,远程操作终端50的承载实体可以是手机、平板、电脑,也可以是智能手表等各类智能穿戴产品。远程操作终端50的功能可以通过APP、小程序等多种方式实现。对于远程操作终端50的具体实现方式本文不作限制。It should be noted that the carrying entity of the
此外,还可以在治疗仪40中设置两个耳机605,在治疗过程中,患者可以听歌曲放松心情。In addition, two
处理方法中的细节可以参考前文实施例,在此不再赘述。For details in the processing method, reference may be made to the foregoing embodiments, and details are not repeated here.
在本实施例中,相比智能化无损化光疗眼镜,光疗智能装置的调节使用更加方便,远程操作终端可以承担更多的个性化功能设置,方便后期的功能拓展和产品升级。In this embodiment, compared with intelligent non-destructive phototherapy glasses, the adjustment and use of the phototherapy smart device is more convenient, and the remote operation terminal can undertake more personalized function settings, which is convenient for later function expansion and product upgrades.
本领域普通技术人员可以理解:附图只是一个实施例的示意图,附图中的模块或流程并不一定是实施本发明所必须的。Those skilled in the art can understand that the accompanying drawing is only a schematic diagram of an embodiment, and the modules or processes in the accompanying drawing are not necessarily necessary for implementing the present invention.
本领域普通技术人员可以理解:实施例中的装置中的模块可以按照实施例描述分布于实施例的装置中,也可以进行相应变化位于不同于本实施例的一个或多个装置中。上述实施例的模块可以合并为一个模块,也可以进一步拆分成多个子模块。Those of ordinary skill in the art can understand that: the modules in the device in the embodiment can be distributed in the device in the embodiment according to the description in the embodiment, and can also be changed and located in one or more devices different from the embodiment. The modules in the above embodiments can be combined into one module, and can also be further divided into multiple sub-modules.
最后应说明的是:以上实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明实施例技术方案的精神和范围。Finally, it should be noted that: the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit them; although the present invention has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that: it can still be Modifications are made to the technical solutions described in the foregoing embodiments, or equivalent replacements are made to some of the technical features; and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210003921.8A CN114392496B (en) | 2022-01-05 | 2022-01-05 | An acousto-optic intelligent non-destructive bone conduction therapy system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210003921.8A CN114392496B (en) | 2022-01-05 | 2022-01-05 | An acousto-optic intelligent non-destructive bone conduction therapy system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114392496A CN114392496A (en) | 2022-04-26 |
| CN114392496B true CN114392496B (en) | 2023-03-21 |
Family
ID=81228472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210003921.8A Active CN114392496B (en) | 2022-01-05 | 2022-01-05 | An acousto-optic intelligent non-destructive bone conduction therapy system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114392496B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112657037A (en) * | 2021-01-11 | 2021-04-16 | 华中科技大学 | Intelligent mental disorder treatment equipment based on variable light |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050137656A1 (en) * | 2003-12-23 | 2005-06-23 | American Environmental Systems, Inc. | Acoustic-optical therapeutical devices and methods |
| US7171271B2 (en) * | 2004-05-11 | 2007-01-30 | Pacesetter, Inc. | System and method for evaluating heart failure using an implantable medical device based on heart rate during patient activity |
| WO2008103982A2 (en) * | 2007-02-23 | 2008-08-28 | The Regents Of The University Of Michigan | System and method for monitoring photodynamic therapy |
| KR101583302B1 (en) * | 2014-04-18 | 2016-01-07 | 부경대학교 산학협력단 | photoacoustic-integrated focused utrasound apparatus for diagnosis and treatment |
| WO2017017799A1 (en) * | 2015-07-29 | 2017-02-02 | 株式会社大木工藝 | Eyeglasses having vital-data-measuring functionality |
| WO2018067876A2 (en) * | 2016-10-05 | 2018-04-12 | Board Of Regents, The University Of Texas System | Nanopulse light therapy |
| CN109965870B (en) * | 2019-02-27 | 2022-04-19 | 杭州诺为医疗技术有限公司 | Method for automatically detecting and stimulating treatment of epilepsy |
| CN113116296A (en) * | 2020-01-13 | 2021-07-16 | 香港城市大学深圳研究院 | Photoacoustic and ultrasonic collaborative diagnosis and treatment system |
| CN111387941A (en) * | 2020-03-16 | 2020-07-10 | 重庆医科大学 | Acousto-optic integrated imaging and treatment system and method |
| CN113368414A (en) * | 2021-07-30 | 2021-09-10 | 重庆海扶医疗科技股份有限公司 | Hand-held ultrasonic therapeutic apparatus |
-
2022
- 2022-01-05 CN CN202210003921.8A patent/CN114392496B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112657037A (en) * | 2021-01-11 | 2021-04-16 | 华中科技大学 | Intelligent mental disorder treatment equipment based on variable light |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114392496A (en) | 2022-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220168568A1 (en) | Peripheral nerve stimulation device for affecting parasympathetic and sympathetic activity to achieve therapeutic effects | |
| US20240342472A1 (en) | Treatment of Headaches by Electrical Stimulation | |
| US6394969B1 (en) | Tinnitis masking and suppressor using pulsed ultrasound | |
| CN114392492B (en) | Intelligent nondestructive phototherapy system | |
| CN107970087A (en) | Ear-in type micro-current and sound tinnitus treatment system and therapeutic apparatus | |
| CN203915230U (en) | A kind of electroacoustic stimulator for the treatment of tinnitus | |
| KR20180116653A (en) | Combined sensation wearable device treating and rehabilitating dizziness | |
| US20220355097A1 (en) | Vibratory neuromodulation | |
| KR20130104978A (en) | Tinnitus treating apparatus and method for stimulaitng of hair cell | |
| CN114392496B (en) | An acousto-optic intelligent non-destructive bone conduction therapy system | |
| CN215231382U (en) | Wake-up prompting system combined with virtual reality technology | |
| CN113694395A (en) | Frequency adjustable electric vibration infrared music therapeutic instrument | |
| WO2018120354A1 (en) | Ultrasonic wave generation device for hearing recovery treatment | |
| Parra | Tinnitus: mechanisms, measures and sound treatments | |
| CN217988181U (en) | An ear-mounted acousto-optic intelligent non-destructive bone conduction therapy instrument | |
| CN204050691U (en) | A kind of ultrasonic therapeutic apparatus with control function | |
| CN201676079U (en) | Audio laser ear disease therapy system | |
| CN218010658U (en) | Intelligent lossless phototherapy glasses | |
| US20250268782A1 (en) | Methods of stimulation using multiple vibrational assemblies | |
| CN220709565U (en) | Transcranial magnetic stimulation instrument control system | |
| RU2300401C1 (en) | Rehabilitation method for treating patients having long bone fractures | |
| Hon | A Clinical Study of Massaging Pressure Therapy for Management of Sensoryneural Hearing Loss | |
| CN118557148A (en) | Senile dementia diagnosis and treatment device | |
| Nanasaheb | A clinical study of massaging pressure therapy for management of sensoryneural hearing loss | |
| Vahidi et al. | Bimodal Neurostimulation in Tinnitus Treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |